GIRARD PARTNERS LTD. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 895 filers reported holding BAXTER INTL INC in Q1 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
GIRARD PARTNERS LTD. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2018$146,000
-62.6%
1,905
-63.9%
0.03%
-64.9%
Q2 2018$390,000
-15.0%
5,280
-25.6%
0.07%
-15.9%
Q4 2017$459,000
-8.6%
7,100
-11.2%
0.09%
-15.4%
Q3 2017$502,000
+1.4%
7,998
-2.2%
0.10%
-2.8%
Q2 2017$495,000
+106.2%
8,179
+76.6%
0.11%
+84.5%
Q1 2017$240,000
+10.1%
4,632
-5.9%
0.06%
-7.9%
Q4 2016$218,000
-28.5%
4,921
-23.3%
0.06%
-38.2%
Q3 2016$305,000
-12.6%
6,417
-16.9%
0.10%
-23.3%
Q2 2016$349,000
-6.2%
7,719
-14.7%
0.13%
-18.4%
Q1 2016$372,000
-2.4%
9,050
-9.4%
0.16%
-11.4%
Q4 2015$381,000
-27.6%
9,991
-37.6%
0.18%
-38.3%
Q3 2015$526,000
-69.9%
16,015
-36.0%
0.30%
-69.5%
Q2 2015$1,750,000
-3.6%
25,027
-5.6%
0.98%
-9.2%
Q1 2015$1,816,000
-9.2%
26,509
-2.8%
1.08%
-13.8%
Q4 2014$1,999,000
-8.7%
27,269
-10.6%
1.25%
-14.7%
Q3 2014$2,189,000
-1.9%
30,505
-1.2%
1.46%
-4.9%
Q2 2014$2,232,000
-11.9%
30,866
-10.3%
1.54%
-14.2%
Q1 2014$2,533,000
+10.0%
34,425
+4.0%
1.80%
-1.7%
Q4 2013$2,303,00033,1141.83%
Other shareholders
BAXTER INTL INC shareholders Q1 2016
NameSharesValueWeighting ↓
Third Point 41,000,000$2,482,140,00022.00%
THUNDERBIRD PARTNERS LLP 1,711,643$103,623,00012.17%
SECTOR GAMMA AS 1,070,333$64,798,0009.42%
Veritas Asset Management LLP 10,179,102$616,243,0004.81%
13D Management LLC 194,807$11,794,0004.18%
Progressive Investment Management Corp 78,316$4,741,0003.69%
Aristotle Capital Management, LLC 6,846,307$414,476,0003.46%
ARGENT CAPITAL MANAGEMENT LLC 1,394,075$84,397,0003.37%
Lipe & Dalton 80,073$4,848,0003.14%
PURA VIDA INVESTMENTS, LLC 125,000$7,568,0003.00%
View complete list of BAXTER INTL INC shareholders